Specimen: Stomach Portion of stomach: Gastric body Gastric antrum Not specified Distal esophagus Proximal duodenum Other (specify): Not specified Procedure: Endoscopic resection Partial gastrectomy, proximal Partial gastrectomy, distal Partial gastrectomy, other (specify): Total gastrectomy Other (specify): Not specified Specimen Size: cm Tumor Site: Gastric cardia Gastric fundus Gastric body Gastric antrum Other (specify): Not specified Tumor Size: Greatest dimension: cm (specify size of largest tumor if multiple tumors are present) Additional dimensions: cm Cannot be determined (see Comment) Tumor Focality: Unifocal Multifocal (number of tumors: ) Cannot be determined Histologic Type: Carcinoid tumor Other (specify): Alternative Histologic Classification: Well-differentiated endocrine tumor, benign behavior Well-differentiated endocrine tumor, uncertain behavior Well-differentiated endocrine carcinoma Histologic Grade: Not applicable GX: Cannot be assessed G1: Low grade G2: Intermediate grade Other (specify): For poorly differentiated (high-grade) neuroendocrine carcinomas, the College of American Pathologists (CAP) checklist for carcinoma of the stomach should be usedMitotic Rate: /10 high-power fields (HPF) Cannot be determined Microscopic Tumor Extension: Cannot be assessed No evidence of primary tumor Tumor invades lamina propria Tumor invades into but not through muscularis mucosae Tumor invades submucosa Tumor invades muscularis propria Tumor invades subserosal tissue without involvement of visceral peritoneum Tumor penetrates serosa (visceral peritoneum) Tumor directly invades adjacent structures () Tumor penetrates to the surface of the visceral peritoneum (serosa) and directly invades adjacent structures () Margins: Proximal Margin: Cannot be assessed Uninvolved by neuroendocrine tumor Involved by neuroendocrine tumor Involved by neuroendocrine cell hyperplasia/dysplasia Distal Margin: Cannot be assessed Uninvolved by neuroendocrine tumor Involved by neuroendocrine tumor Involved by neuroendocrine cell hyperplasia/dysplasia Omental (Radial) Margin: Cannot be assessed Uninvolved by neuroendocrine tumor Involved by neuroendocrine tumor Deep Margin (applies to endoscopic resections): Cannot be assessed Uninvolved by tumor Involved by tumor Not applicable Lateral Mucosal Margins (applies to endoscopic resections): Cannot be assessed Uninvolved tumor Involved by tumor Not applicable Other Margin(s) (): Not applicable Cannot be assessed Uninvolved by neuroendocrine tumor Involved by neuroendocrine tumor Involved by neuroendocrine cell hyperplasia/dysplasia Distance of tumor from closest margin: at Lymph-Vascular Invasion: Not identified Present Indeterminate Perineural Invasion: Not identified Present Indeterminate Pathologic Staging (pTNM) TNM Descriptors: m (multiple primary tumors) r (recurrent) y (posttreatment) Primary Tumor (pT): pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pTis: Carcinoma in situ/dysplasia (tumor size less than 0.5 mm), confined to mucosa pT1: Tumor invades lamina propria or submucosa and 1 cm or less in size pT2: Tumor invades muscularis propria or more than 1 cm in size pT3: Tumor penetrates subserosa pT4: Tumor invades visceral peritoneum (serosal) or other organs or adjacent structures Regional Lymph Nodes (pN): Cannot be assessed pN0: No regional lymph node metastasis ( 0 / ) pN1: Metastasis in regional lymph nodes ( / ) No nodes submitted or found Distant Metastasis (pM): Not applicable pM1: Distant metastasis at Ancillary Studies: Ki-67 index: ≤2% >2% to 20% >20% Other (specify): Not performed Additional Pathologic Findings: Atrophic gastritis Intestinal metaplasia of gastric mucosa Glandular dysplasia of gastric mucosa Endocrine cell hyperplasia Absence of parietal cells Tumor necrosis Other, specify: Comment(s):